The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia

被引:108
|
作者
Velligan, Dawn I. [1 ]
Diamond, Pamela M. [4 ]
Mintz, Jim [1 ]
Maples, Natalie [1 ]
Li, Xueying [1 ]
Zeber, John [1 ,5 ]
Ereshefsky, Larry [2 ]
Lam, Yui-Wing F. [3 ]
Castillo, Desiree [1 ]
Miller, Alexander L. [1 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78284 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacotherapy Educ & Res, San Antonio, TX 78284 USA
[3] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78284 USA
[4] Univ Texas Houston, Sch Publ Hlth, Ctr Hlth Promot & Prevent Res, Houston, TX USA
[5] Vet Affairs HSR&D, VERDICT, San Antonio, TX USA
关键词
D O I
10.1093/schbul/sbm111
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Cognitive adaptation training (CAT) is a psychosocial treatment that uses environmental supports such as signs, checklists, alarms, and the organization of belongings to cue and sequence adaptive behaviors in the home. Ninety-five outpatients with schizophrenia (structured clinical interview for diagnosis, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) were randomly assigned to (1) Full-CAT (CAT focused on many aspects of community adaptation including grooming, care of living quarters, leisure skills, social and role performance, and medication adherence), (2) Pharm-CAT (CAT focused only on medication and appointment adherence), or (3) treatment as usual (TAU). Treatment lasted for 9 months, and patients were followed for 6 months after the withdrawal of home visits. Medication adherence (assessed during unannounced, in-home pill counts) and functional outcomes were assessed at 3-month intervals. Results of mixed-effects regression models indicated that both CAT and Pharm-CAT treatments were superior to TAU for improving adherence to prescribed medication (P < .0001). Effects on medication adherence remained significant when home visits were withdrawn. Full-CAT treatment improved functional outcome relative to Pharm-CAT and TAU (P < .0001). However, differences for functional outcome across groups decreased following the withdrawal of home visits and were no longer statistically significant at the 6-month follow-up. Survival time to relapse or significant exacerbation was significantly longer in both CAT and Pharm-CAT in comparison to TAU (.004). Findings indicate that supports targeting medication adherence can improve and maintain this behavior. Comprehensive supports targeting multiple domains of functioning are necessary to improve functional outcomes. Maintenance of gains in functional outcome may require some form of continued intervention.
引用
收藏
页码:483 / 493
页数:11
相关论文
共 50 条
  • [31] Expanding patient access to quality medication-related information: the potential of medication hotlines to improve patient adherence in schizophrenia
    Amy R. Pettit
    Steven C. Marcus
    [J]. Social Psychiatry and Psychiatric Epidemiology, 2015, 50 : 735 - 737
  • [32] Medication Synchronization Programs Improve Adherence To Cardiovascular Medications And Health Care Use
    Krumme, Alexis A.
    Glynn, Robert J.
    Schneeweiss, Sebastian
    Gagne, Joshua J.
    Dougherty, J. Samantha
    Brill, Gregory
    Choudhry, Niteesh K.
    [J]. HEALTH AFFAIRS, 2018, 37 (01) : 125 - 133
  • [33] Development of a Culturally Tailored Motivational Interviewing-Based Intervention to Improve Medication Adherence in South Asian Patients
    Singh, Pavneet
    Campbell, Tavis
    LeBlanc, Pamela
    King-Shier, Kathryn M.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 757 - 765
  • [34] Medication compliance, adherence, and persistence: Current status of behavioral and educational interventions to improve outcomes
    Touchette, Daniel R.
    Shapiro, Nancy L.
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2008, 14 (06): : S2 - S10
  • [35] Patient-Tailored Interventions to Improve Specialty Medication Adherence: Results from a Prospective Randomized Controlled Trial
    Kibbons, Amanda M.
    Moore, Ryan
    Choi, Leena
    Zuckerman, Autumn D.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2023, 136 (07): : 694 - +
  • [36] Medication adherence levels and differential use of mental-health services in the treatment of schizophrenia
    Ascher-Svanum H.
    Zhu B.
    Faries D.
    Furiak N.
    Montgomery W.
    [J]. BMC Research Notes, 2 (1)
  • [37] The relationship of antipsychotic medication class and adherence with treatment outcomes and costs for Florida Medicaid beneficiaries with schizophrenia
    Becker, Marion A.
    Young, M. Scott
    Ochshorn, Ezra
    Diamond, Ronald J.
    [J]. ADMINISTRATION AND POLICY IN MENTAL HEALTH AND MENTAL HEALTH SERVICES RESEARCH, 2007, 34 (03) : 307 - 314
  • [38] The Relationship of Antipsychotic Medication Class and Adherence with Treatment Outcomes and Costs for Florida Medicaid Beneficiaries with Schizophrenia
    Marion A. Becker
    M. Scott Young
    Ezra Ochshorn
    Ronald J. Diamond
    [J]. Administration and Policy in Mental Health and Mental Health Services Research, 2007, 34 : 307 - 314
  • [39] Interventions to Improve Medication Adherence in Patients with Schizophrenia or Bipolar Disorders: A Systematic Review and Meta-Analysis
    Loots, Elke
    Goossens, Eva
    Vanwesemael, Toke
    Morrens, Manuel
    Van Rompaey, Bart
    Dilles, Tinne
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (19)
  • [40] Pairwise comparisons of three medication adherence outcomes in adolescents who use alcohol
    Kirkland, Anna E.
    Tomko, Rachel L.
    Green, ReJoyce
    Browning, Brittney D.
    Ferguson, Pamela L.
    Liu, Helen
    Miranda Jr, Robert
    Gray, Kevin M.
    Squeglia, Lindsay M.
    [J]. ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 (12): : 2375 - 2385